These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1047087

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.
    Fong IW, Engelking ER, Kirby WM.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):939-44. PubMed ID: 938023
    [Abstract] [Full Text] [Related]

  • 27. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T, Mitsuhashi S.
    Arzneimittelforschung; 1977 Jun; 27(1):89-93. PubMed ID: 576821
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Should resistance to methicillin of RH mutant staphylococci be necessarily attributed to cephalosporins?].
    Joly B, Cluzel R, Henri Ph, Sirot D.
    Pathol Biol (Paris); 1975 Apr; 23(4):291-7. PubMed ID: 1097992
    [Abstract] [Full Text] [Related]

  • 30. Distribution of beta-lactamases A and B in some groups of Yersinia enterocolitica and their role in resistance.
    Cornelis G.
    J Gen Microbiol; 1975 Dec; 91(2):391-402. PubMed ID: 1043915
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The in vitro spectrum of the cephalosporins.
    Washington JA.
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [Abstract] [Full Text] [Related]

  • 33. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
    Kernodle DS, Classen DC, Burke JP, Kaiser AB.
    JAMA; 1990 Feb 16; 263(7):961-6. PubMed ID: 2299764
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
    Sawai T, Ando-Kuroda I, Murata T, Yamagishi S.
    J Pharmacobiodyn; 1980 Jul 16; 3(7):364-6. PubMed ID: 7009827
    [Abstract] [Full Text] [Related]

  • 39. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A, Durosoir JL, Saliou P.
    Pathol Biol (Paris); 1979 Dec 16; 27(10):649-54. PubMed ID: 395496
    [Abstract] [Full Text] [Related]

  • 40. Newer cephalosporins and cephamycins--a review.
    Norrby R.
    Scand J Infect Dis Suppl; 1978 Dec 16; (13):83-7. PubMed ID: 356183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.